{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:43:19Z","timestamp":1791924199805,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":1461,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1038\/ki.2012.444","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T13:54:16Z","timestamp":1358344456000},"page":"511-516","source":"Crossref","is-referenced-by-count":131,"title":["Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease"],"prefix":"10.1016","volume":"83","author":[{"given":"Helene","family":"Munyentwali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khedidja","family":"Bouachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Audard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Remy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"Mojaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Desch\u00eanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre M.","family":"Ronco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle M.","family":"Plaisier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine Y.","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2012.444_bb0010","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.V85769","article-title":"Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children","volume":"8","author":"Tarshish","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2012.444_bb0015","series-title":"Pediatric Nephrology","first-page":"543","article-title":"Steroid-sensitive idiopathic nephrotic syndrome in children","author":"Niaudet","year":"2004"},{"key":"10.1038\/ki.2012.444_bb0020","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2215\/CJN.05691108","article-title":"Long-term outcome of biopsy proven, frequently relapsing minimal-change nephrotic syndrome in children","volume":"4","author":"Kyrieleis","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2012.444_bb0025","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1053\/ajkd.2003.50116","article-title":"Steroid-sensitive nephrotic syndrome: from childhood to adulthood","volume":"41","author":"Fakhouri","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2012.444_bb0030","first-page":"CD002290","article-title":"Non-corticosteroid treatment for nephrotic syndrome in children","volume":"23","author":"Hodson","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1038\/ki.2012.444_bb0035","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1053\/j.ajkd.2003.08.011","article-title":"Mycoph\u00e9nolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome","volume":"42","author":"Bagga","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2012.444_bb0040","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.ajkd.2007.02.270","article-title":"Long-term outcome after cyclophosphamide treatment in children with steroid dependent and frequently relapsing minimal change nephrotic syndrome","volume":"49","author":"Kyrieleis","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2012.444_bb0045","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","article-title":"IDEC-C2B8(Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non Hodgkin\u2019s lymphoma","volume":"90","author":"Maloney","year":"1997","journal-title":"Blood"},{"key":"10.1038\/ki.2012.444_bb0050","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1002\/art.22046","article-title":"Long-term comparison of rituximab treatment for refractory systemic lupus erythematous and vasculitis: Remission, relapse, and re-treatment","volume":"54","author":"Smith","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2012.444_bb0055","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.pharmthera.2010.01.001","article-title":"Targeting B cells in immune-mediated inflammatory disease: a comprehensive review of mechanisms of action and identification of biomarkers","volume":"125","author":"D\u00f6rner","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1038\/ki.2012.444_bb0060","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(02)11042-7","article-title":"Rituximab for idiopathic membranous nephropathy","volume":"360","author":"Remuzzi","year":"2002","journal-title":"Lancet"},{"key":"10.1038\/ki.2012.444_bb0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.ki.5002628","article-title":"Rituximab treatment of idiopathic membranous nephropathy","volume":"73","author":"Fervenza","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2012.444_bb0070","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00467-009-1226-6","article-title":"Nephrotic syndrome and rituximab: facts and perspectives","volume":"24","author":"Haffner","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2012.444_bb0075","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00467-008-0814-1","article-title":"Rituximab treatment for severe steroid-or cyclosporine dependent nephrotic syndrome: A multicentric series of 22 cases","volume":"23","author":"Guigonis","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2012.444_bb0080","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00467-009-1191-0","article-title":"Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children","volume":"24","author":"Kamei","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2012.444_bb0085","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00467-010-1465-6","article-title":"Rituximab efficiency in children with steroid-dependent nephrotic syndrome","volume":"25","author":"Sellier-Leclerc","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2012.444_bb0090","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2215\/CJN.03470410","article-title":"Efficacy and safety of treatment with rituximab for difficult steroid-resistant and-dependent nephrotic syndrome: multicentric report","volume":"5","author":"Gulati","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2012.444_bb0095","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00467-009-1377-5","article-title":"Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine","volume":"25","author":"Fujinaga","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2012.444_bb0100","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/ndt\/gfr548","article-title":"Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome","volume":"27","author":"Kemper","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2012.444_bb0105","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2215\/CJN.09421010","article-title":"Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial","volume":"6","author":"Ravani","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2012.444_bb0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00467-011-1997-4","article-title":"Short-term efficacy of rituximab versus tacrolimus in steroid-dependent nephrotic syndrome","volume":"27","author":"Sinha","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2012.444_bb0115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.ajkd.2006.10.015","article-title":"Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations","volume":"49","author":"Fran\u00e7ois","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2012.444_bb0120","first-page":"308","article-title":"Rituximab for steroid-dependent nephrotic syndrome","volume":"74","author":"Beco","year":"2010","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.2012.444_bb0125","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.2169\/internalmedicine.48.2435","article-title":"Successful use of single-dose rituximab for the maintenance of remission in a patient with steroid-resistant nephrotic syndrome","volume":"48","author":"Kurosu","year":"2009","journal-title":"Intern Med"},{"key":"10.1038\/ki.2012.444_bb0130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5414\/CN107092","article-title":"Rituximab in adult patients with immunosuppressive-dependent minimal change disease","volume":"76","author":"Hoxha","year":"2011","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.2012.444_bb0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJM199401063300102","article-title":"Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome","volume":"330","author":"Dantal","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2012.444_bb0140","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1056\/NEJM200102013440517","article-title":"Transmission of glomerular permeability factor from a mother to her child","volume":"344","author":"Kemper","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2012.444_bb0145","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","article-title":"Pathogenesis of lipoid nephrosis: a disorder of T-cell function","volume":"2","author":"Shaloub","year":"1974","journal-title":"Lancet"},{"key":"10.1038\/ki.2012.444_bb0150","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10157-011-0465-6","article-title":"Rituximab and minimal change nephrotic syndrome: a therapeutic option","volume":"15","author":"Takei","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"10.1038\/ki.2012.444_bb0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clim.2009.03.532","article-title":"New insights into the pathophysiology of idiopathic nephrotic syndrome","volume":"133","author":"Bruneau","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1038\/ki.2012.444_bb0160","doi-asserted-by":"crossref","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","article-title":"Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis","volume":"3","author":"Fornoni","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1038\/ki.2012.444_bb0165","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2215\/CJN.00570109","article-title":"Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis","volume":"4","author":"Fernandez-Fresnedo","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2012.444_bb0170","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00467-011-1778-0","article-title":"Rituximab for refractory cases of childhood nephrotic syndrome","volume":"26","author":"Kari","year":"2011","journal-title":"Pediatr Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815557712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815557712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T02:24:49Z","timestamp":1644114289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815557712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0085253815557712"],"URL":"https:\/\/doi.org\/10.1038\/ki.2012.444","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}